Sadie Slocum, APRN
Family · Bay St Louis, MSNPI 1053073007
Payments from drug & device makers
Across 95 payments — averaging $51.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Spinal Simplicity, LLC$456
- Globus Medical$384
- Nevro Corp.$339
- Averitas Pharma Inc.$170
- Lilly USA, LLC$104
- plus $467 from 14 others
What the payments were for
- Travel & lodging$2,48151%
- Food & beverage$2,40449%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 23 | $2,966 |
| Spinal Simplicity, LLC | 3 | $456 |
| Globus Medical | 22 | $384 |
| Nevro Corp. | 17 | $339 |
| Averitas Pharma Inc. | 2 | $170 |
| Lilly USA, LLC | 6 | $104 |
| Painteq LLC | 4 | $97 |
| Lundbeck LLC | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Relievant Medsystems, Inc. | 1 | $27 |
| SPR Therapeutics, Inc | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| UCB, Inc. | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Curonix LLC | 1 | $20 |
| Valinor Pharma, LLC | 1 | $20 |
| Amgen | 1 | $18 |
| Si-bone, Inc. | 1 | $18 |
| Biogen | 1 | $17 |
| Argenx US, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$1,512
- HA MINUTEMAN G3-R$390
- Senza$254
- Qutenza$146
- WaveWriter Alpha Prime 16$129
How this compares
$4,885 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 236 | $2,539 |
| Diclofenac Sodium | 15 | $632 |
| Celecoxib | 24 | $590 |
| Tizanidine Hcl | 53 | $414 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $334 |
| Baclofen | 34 | $305 |
| Methocarbamol | 25 | $270 |
| Duloxetine Hcl | 18 | $200 |
| Cyclobenzaprine Hcl | 36 | $109 |
| Meloxicam | 18 | $38 |
Paid to pharmacies, not to this prescriber.
Other family in Bay St Louis
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.